Blog | Rancho BioSciences

John Reynders, PhD, MBA, newly appointed to the Rancho BioSciences Board of Directors

AI in Drug Discovery Press Release New

Former Client and Three-Decade Data Sciences Leader John Reynders, PhD, Joins Rancho BioSciences Leadership on Board of Directors

Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, Dr. Reynders will bring...

Rancho BioSciences · Jul 14, 2026 5:08:42 AM

Data Curation and Management Single-cell AI in Drug Discovery Multi-omics Press Release New

Rancho BioSciences Launches OmicsHQ™: a Comprehensive, Curated, Multi-Omics Data Platform Built to Accelerate Drug Discovery

Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQ^TM, a unified catalog of...

Rancho BioSciences · May 20, 2026 7:25:28 AM

AI in Drug Discovery Press Release New

Rancho BioSciences Formally Appoints Amar Thyagarajan, PhD, as Chief Commercial Officer

Rancho BioSciences today formally announced the appointment of Amar Thyagarajan, PhD, as Chief Commercial Officer. Dr. Thyagarajan, who joined Rancho...

Rancho BioSciences · Apr 22, 2026 8:57:58 PM

AI in Drug Discovery Press Release

Chris O’Brien Appointed as CEO to Deliver AI-Ready Data Solutions

Rancho BioSciences today announced the appointment of Chris O’Brien as Chief Executive Officer. O’Brien will lead the company’s next phase of growth...

Rancho BioSciences · Mar 24, 2026 11:35:33 AM